Neil Thompson
Vendite & Marketing presso POLYPEPTIDE GROUP AG
Patrimonio netto: 41 539 $ in data 31/05/2024
Profilo
Mr. Neil J.
Thompson is a Director-Global Sales & Marketing at PolyPeptide Group AG.
Mr. Thompson was previously employed as a Product Manager-Peptide by Bachem (U.K.) Ltd., a Product Manager by Bachem AG, and an Assistant Manager-Production by Peninsula Laboratories Europe Ltd.
He received his undergraduate degree from Liverpool John Moores University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
POLYPEPTIDE GROUP AG
0.00% | 31/12/2023 | 1 122 ( 0.00% ) | 41 539 $ | 31/05/2024 |
Posizioni attive di Neil Thompson
| Società | Posizione | Inizio |
|---|---|---|
| POLYPEPTIDE GROUP AG | Vendite & Marketing | 01/01/2022 |
Precedenti posizioni note di Neil Thompson
| Società | Posizione | Fine |
|---|---|---|
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Corporate Officer/Principal | 01/01/2003 |
Bachem (U.K.) Ltd.
 Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Corporate Officer/Principal | 01/01/2003 |
Formazione di Neil Thompson
| Liverpool John Moores University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| POLYPEPTIDE GROUP AG | Health Technology |
| Aziende private | 2 |
|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Bachem (U.K.) Ltd.
Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Health Technology |
- Borsa valori
- Insiders
- Neil Thompson
